Bladder transitional cell carcinoma stage II

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
1 Unique IMPs
0 Commercial trials
Drug classes (ATC)
L Oncology (ATC L) 1
Mechanism of action (INN-stem analysis)
Checkpoint inhibitor (PD-L1) 1 substance
Phase II: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase II

1 trial
  • Fundacion Cris De Investigacion Para Vencer El Cancer Academic
    DURVALUMAB
    2024-512502-26-00 1 country 2019 n=80
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Fundacion Cris De Investigacion Para Vencer El Cancer Academic 1 Phase II 0
New trials by year
2019
1
← All indication landscapes